Handgrip Strength Increases the Pressure in the Portal and Left Gastric Veins in Cirrhotic Patients
Shanxi Provincial People's Hospital
64 participants
Dec 31, 2025
OBSERVATIONAL
Conditions
Summary
1.Background Handgrip strength , a core indicator of muscle function, has been confirmed to be significantly associated with the clinical prognosis of patients with liver cirrhosis. However, no studies have explored its correlation with portal venous hemodynamics. 2. Objective The purpose of the study is to examine the effects of Handgrip strength on portal vein and left gastric vein pressure, blood flow velocity and direction in patients with liver cirrhosis. 3\. Method: observational study. Detection Timing: Doppler ultrasound was employed to determine the portal flow velocity and direction at baseline and during the handgrip strength test in cirrhotic patients with a history of variceal bleeding. Three days later, prior to TIPS placement, the pressures in the portal pressure and gastric vein pressure were measured both before and after handgrip strength. Furthermore, carvedilol and vasoactive drugs were discontinued three days before the study commenced. 4. Elaboration of the Research Hypothesis 4.1. Core Hypothesis The handgrip strength level in patients with liver cirrhosis is correlated with portal venous system hemodynamic indices. Specifically, enhanced handgrip strength may affect portal hypertension and the hemodynamics of varicose veins by improving systemic muscle function or circulatory status. 4.2. Speculation on potential mechanisms Association between muscle function and circulation: As a representative of systemic muscle function, increased handgrip strength may reflect an increase in cardiac output or changes in splanchnic vascular resistance, thereby influencing portal venous hemodynamics.
Eligibility
Inclusion Criteria1
- adult patients (≥18 years of age) with cirrhosis and a history of variceal bleeding, who were preparing for TIPS creation for secondary prophylaxis against variceal bleeding
Exclusion Criteria11
- Severe congestive heart failure, or severe untreated valvular heart disease
- Moderate to severe pulmonary hypertension
- Uncontrolled systemic infection
- Lesions (e.g., cysts) or tumors in the liver parenchyma that preclude TIPS creation
- Overt hepatic encephalopathy
- Unrelieved biliary obstruction
- Child-Pugh score \> 13
- Model for end-stage liver disease (MELD) score \> 18
- International normalized ratio (INR) \> 5
- Platelet count \< 20×109/mm3
- Participants who had undergone hand or wrist surgery within the previous 3 months or were unable to hold the dynamometer with the testing hand were excluded from the study.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Jamar Hand Dynamometer, from Illinois, USA. Maximum handgrip strength was measured three times, with each measurement lasting 3 seconds and a 1-minute interval between tests
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07289698